Ergebnis der Suchanfrage nach Joint
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 3mehr
- 2
IntercityHotel brand comes to Rotterdam-Schiedam
Ein Dokumentmehr Customcells launches development partnership with OneD
mehrCroma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
Vienna (ots/PRNewswire) - Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China. The randomised, multi-centre, evaluator blinded, parallel group, active ...
mehrG20: International platform of foundations and philanthropy calls upon the G20 Heads to increase actions on climate change and future resilience
2 DokumentemehrGerman airspace powered by Rohde & Schwarz
mehrJoint Statement: health organisations define EHDS’ opt-out required for life-saving research
Ein DokumentmehrPMG Presse-Monitor GmbH & Co. KG
PMG Presse-Monitor strengthens management team: Welcomes Michelle Harold as new VP Global Sales
mehrCotton Made in Africa and African Cotton Foundation launched Innovations Club
mehrCroma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
Vienna (ots/PRNewswire) - Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom ("UK"), and Ireland. Further markets including Brazil will follow by the end of 2023. The anaesthetic cream ...
mehr- 5
Strong Interest in Renewable Materials: Record Conference Attendance and Three Winners of the “Renewable Material of the Year 2023” Innovation Award
Ein Dokumentmehr Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee
Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...
mehrPM: DHL Global Forwarding setzt auf Eisenbahnnetz der Vereinigten Arabischen Emirate als zentrales Transportmittel / PR: DHL Global Forwarding to utilize the UAE National Rail Network as one of its primary modes of transportation for its operations
2 DokumentemehrA24 and LEONINE Studios establish joint label for future releases
mehrHellmann: Natasha Solano-Vesela appointed Global Airfreight Director Perishables
mehrCYBICS Conference on the EU Cyber Resilience Act: Industry wants to be on the safe side
CYBICS Conference on the EU Cyber Resilience Act: Industry wants to be on the safe side Experts from BSI, BOSCH, VOITH, VDE summarize requirements and measures and call on all manufacturers to take immediate action Frankfurt / Duesseldorf, May 11, 2023 – There was considerable interest among the participants of the seventh CYBICS conference on the challenges of IT ...
mehrCroma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets
Vienna (ots/PRNewswire) - Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these ...
mehrKoehler Renewable Energy receives approval for Höhlerberg wind farm project with two wind turbines
mehr/C O R R E C T I O N -- Croma-Pharma/
Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...
mehrCroma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter
Vienna (ots/PRNewswire) - - Company reports strong financial results for 2022 with 27% revenue growth in 2022 and significantly increased margins - Growth driven by launch of Letybo® and its catalytic effect on the existing portfolio as well as strong market growth - Continued market share gains, strategic mid-term ...
mehrAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
mehrFraunhofer-Institut für Produktionstechnologie IPT
Joint expertise from industry and research: New regulations standardize optical coherence tomography
mehrHellmann achieves another record result in 2022
mehrTrendyol and PASHA Holding sign an agreement for a joint venture in the Azerbaijan market
Istanbul (ots) - Trendyol, the leading e-commerce platform in Türkiye and one of the largest technology companies in Europe, has today announced that it is entering the Azerbaijan market. With an agreement signed with Baku-based PASHA Holding, one of the largest conglomerates in the Caucasus region, to establish a joint venture company to provide e-commerce services ...
mehrIdeal for chips, bars, and cosmetics: Koehler Paper and Nissha Metallizing Solutions to showcase new metallized and sustainable “METIVO® Advanced” packaging paper at Interpack 2023
mehr- 10
Press Release: Investment of over 10 Million Euros - eROCKIT introduces Indian investor Motovolt
mehr Innovative regeneration for handball players: Reboots becomes official supplier of the German Handball Federation
mehrGoals for 2022 achieved: DEKRA increases revenue and transforms for the future
mehrNew platform sheds light on the bioeconomy
Harnessing innovation to build a bio-based, climate-neutral and circular economy – that is the goal of Germany’s National Bioeconomy Strategy. But is Germany on track, and does development align with the overarching Sustainable Development Goals? Please excuse any double sendings Joint Press release Oeko-Institut and Symobio 2.0 Darmstadt, 18. April ...
Ein DokumentmehrDissolution of licence agreements in Germany: Avis-Budget loses station infrastructure in 7 of 16 German states
Hamburg, Germany (ots) - - Avis-Budget surprisingly terminates licensees - Station network in 7 of 16 German federal states becomes independent After 30 years of successful cooperation, Avis-Budget and the German licensee Wucherpfennig & Krohn will go their separate ways from 31. 12. 2023. The contract was ...
mehr